Tresiba injection in the morning or evening trial

Tresiba injection in the morning or evening trial - TIME trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024077

Enrollment

100

Registered

2016-10-01

Start date

2015-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

injection of insulin degludec in the morning injection of insulin degludec in the evening

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 2 diabetes

Exclusion criteria

Exclusion criteria: The exclusion criteria were pregnant or nursing women and subjects in whom the physician deemed IDeg treatment inappropriate.

Design outcomes

Primary

Measure	Time frame
blood glucose profile	—

Countries

Japan

Contacts

Public ContactSeika Shimoda

Kumamoto university Faculty of Life Sciences

sshimoda@gpo.kumamoto-u.ac.jp096-373-5169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026